Overview of the Complexities in Diagnosing Treating and Preventing Tuberculosis along with the Most Effective Dosage Plans

Authors: Awan SJ*, Siddiqui K, Masood F, Muzammil A, Shafique F, Atiq S, Gillani I, Sohail N and Inayat SSohail N and Inayat S

DOI: 10.23880/ipcm-16000236

Volume 7, Issue 1

Abstract

Mycobacterium tuberculosis is the name of the bacterium that causes tuberculosis (TB), which typically affects the lungs. Lifetime exposure to TB bacteria increases the risk of developing TB by 5–10%. A person’s likelihood of getting sick rises if they lead an unhealthy lifestyle or have a compromised immune system. A person may take several months before showing symptoms of active TB disease. As a result, getting medical help may take longer, and the virus may spread to more people. Rifampicin, isoniazid, pyrazinamide, and ethambutol are given as part of the traditional treatment for pulmonary TB during the first two months, and then rifampicin and isoniazid are given for the following four months. For the treatment of multidrugresistant TB, levofloxacin, moxifloxacin, and bedaquiline are suggested.

Keywords: Tuberculosis; Dosage Plans; Bacteria

View PDF